Trial · NCT03990363
Results by group56
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 56
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | High Dose Versus Placebo | 0.8300 | 95% Confidence Interval 0.6810 to 1.012 | mg/g | |
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | High Dose and Intermediate Dose Combined Versus Allopurinol | 1.043 | 95% Confidence Interval 0.8793 to 1.237 | mg/g | |
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Intermediate Dose Versus Placebo | 0.8369 | 95% Confidence Interval 0.6887 to 1.017 | mg/g | |
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Low Dose Versus Placebo | 0.8499 | 95% Confidence Interval 0.6984 to 1.034 | mg/g | |
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | High Dose Versus Allopurinol | 1.037 | 95% Confidence Interval 0.8506 to 1.265 | mg/g | |
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Intermediate Dose Versus Allopurinol | 1.046 | 95% Confidence Interval 0.8603 to 1.272 | mg/g | |
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Low Dose Versus Allopurinol | 1.062 | 95% Confidence Interval 0.8725 to 1.293 | mg/g | |
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Allopurinol Versus Placebo | 0.8001 | 95% Confidence Interval 0.6573 to 0.9739 | mg/g | |
| Urinary Albumin to Creatinine Ratio (uACR) (mg/g) Change From Baseline at 12 Months (Visit 10), Repeated Measures Mixed Model (MMRM) | Switch Dose PA5 Versus Placebo | 1.016 | 95% Confidence Interval 0.7437 to 1.388 | mg/g | |
| Serum Uric Acid (sUA) (mg/dL) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | High Dose Versus Placebo | 0.5098 | 95% Confidence Interval 0.4701 to 0.5528 | mg/dL | |
| Serum Uric Acid (sUA) (mg/dL) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Intermediate Dose Versus Placebo | 0.5810 | 95% Confidence Interval 0.5362 to 0.6295 | mg/dL | |
| Serum Uric Acid (sUA) (mg/dL) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Low Dose Versus Placebo | 0.6096 | 95% Confidence Interval 0.5623 to 0.6609 | mg/dL | |
| Serum Uric Acid (sUA) (mg/dL) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | High Dose Versus Allopurinol | 0.8184 | 95% Confidence Interval 0.7544 to 0.8878 | mg/dL | |
| Serum Uric Acid (sUA) (mg/dL) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Interemdiate Dose Versus Allopurinol | 0.9327 | 95% Confidence Interval 0.8604 to 1.011 | mg/dL | |
| Serum Uric Acid (sUA) (mg/dL) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Low Dose Versus Allopurinol | 0.9786 | 95% Confidence Interval 0.9024 to 1.061 | mg/dL | |
| Serum Uric Acid (sUA) (mg/dL) Change From Baseline at 6 Months (Visit 8), Repeated Measures Mixed Model (MMRM) | Allopurinol Versus Placebo | 0.6229 | 95% Confidence Interval 0.5744 to 0.6755 | mg/dL | |
| Serum Uric Acid (sUA) Change From Baseline at 12 Months (Visit 10), Repeated Measures Mixed Model (MMRM) | Switch Dose PA5 Versus Placebo | 0.5540 | 95% Confidence Interval 0.4825 to 0.6362 | mg/dL | |
| Estimated Glomerular Filtration Rate (eGFR) (mL/Min/1.73 m²) Change From Baseline at 6 Months (V8), Repeated Measures Mixed Model (MMRM) | High Dose Versus Placebo | 1.009 | 95% Confidence Interval 0.9647 to 1.056 | mL/min/1.73 m² | |
| Estimated Glomerular Filtration Rate (eGFR) (mL/Min/1.73 m²) Change From Baseline at 6 Months (V8), Repeated Measures Mixed Model (MMRM) | Intermediate Dose Versus Placebo | 0.9730 | 95% Confidence Interval 0.9307 to 1.017 | mL/min/1.73 m² | |
| Estimated Glomerular Filtration Rate (eGFR) (mL/Min/1.73 m²) Change From Baseline at 6 Months (V8), Repeated Measures Mixed Model (MMRM) | Low Dose Versus Placebo | 1.010 | 95% Confidence Interval 0.9660 to 1.056 | mL/min/1.73 m² |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03990363/results